SG Americas Securities, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 57 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2017. The put-call ratio across all filers is 1.80 and the average weighting 0.7%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$21,000
-84.2%
10,601
-90.0%
0.00%
-100.0%
Q4 2020$133,000
-94.0%
106,353
-91.3%
0.00%
-92.9%
Q3 2020$2,211,000
+190.2%
1,228,106
+1251.8%
0.01%
+133.3%
Q2 2020$762,000
+1037.3%
90,848
+615.2%
0.01%
+500.0%
Q1 2020$67,000
-54.7%
12,703
-29.2%
0.00%0.0%
Q1 2017$148,00017,9480.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,563,925$16,717,00029.31%
Cormorant Asset Management, LP 2,000,000$13,580,0001.50%
Perceptive Advisors 2,701,023$18,339,0001.18%
Fosun International Ltd 700,071$4,753,0000.53%
Ghost Tree Capital, LLC 200,000$1,358,0000.22%
ACUTA CAPITAL PARTNERS, LLC 81,302$552,0000.21%
IFP Advisors, Inc 300,000$2,037,0000.11%
CONNING INC. 351,280$2,385,0000.10%
WOODSTOCK CORP 39,931$271,0000.06%
Yellowstone Partners, LLC 15,944$108,0000.04%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders